Form 8-K - Current report:
SEC Accession No. 0001558370-21-000791
Filing Date
2021-02-08
Accepted
2021-02-08 07:01:23
Documents
13
Period of Report
2021-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20210205x8k.htm   iXBRL 8-K 34412
2 EX-99.1 tgtx-20210205xex99d1.htm EX-99.1 39771
  Complete submission text file 0001558370-21-000791.txt   206835

Data Files

Seq Description Document Type Size
3 EX-101.SCH tgtx-20210205.xsd EX-101.SCH 2698
4 EX-101.LAB tgtx-20210205_lab.xml EX-101.LAB 16172
5 EX-101.PRE tgtx-20210205_pre.xml EX-101.PRE 11165
6 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210205x8k_htm.xml XML 4781
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 21598508
SIC: 2834 Pharmaceutical Preparations